Journal of Cancer Research and Therapeutics Close
 

Figure 4: Graphic representation of the groupwise distribution of neutrophil gelatinase-associated lipocalin levels in patients of carcinoma cervix with more than or equal to 8 weeks of treatment

Figure 4: Graphic representation of the groupwise distribution of neutrophil gelatinase-associated lipocalin levels in patients of carcinoma cervix with more than or equal to 8 weeks of treatment